The final, formatted version of the article will be published soon. Background Percutaneous left atrial appendage (LAA) closure (LAAC) is a proven stroke prevention strategy for atrial fibrillation ...
Abbott said last week that it has received clearance to sell a device for treating life-threatening openings in the hearts of premature infants. The Food and Drug Administration clearance and CE mark ...
Abstract: Percutaneous Left Atrial Appendage Closure (LAAC) is a minimally invasive procedure to prevent thromboembolic events in atrial fibrillation patients. The procedure's success relies on ...
NORTH CHARLESTON, S.C. (WCIV) — (UPDATE) – North Charleston police safely intervened early Thursday after a man threatened to jump from the Don Holt Bridge, prompting hours-long closures and traffic ...
Abbott received FDA clearance for a new delivery system designed to simplify PDA closure in premature infants weighing as little as 2 lb. FDA clearance was granted for a delivery system designed ...
The Amplatzer Piccolo delivery system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced today that it received FDA clearance for its Amplatzer Piccolo delivery system for use with the ...
On Nov. 21, Tyson Foods announced it would permanently close its beef processing facility in Lexington, Nebraska, effective Jan. 20. The company also announced it would convert its Amarillo, Texas, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback